Cormedix Inc (CRMD)

$11.17 -0.14 (-1.24%)
Market Cap 882.85M
Revenue (ttm) 43.47M
Net Income (ttm) -17.93M
EPS (ttm) N/A
PE Ratio 14.93
Forward PE 6.04
Profit Margin -41.25%
Debt to Equity Ratio 0.00
Volume 1,841,800
Avg Vol 3,391,300
Day's Range N/A - N/A
Shares Out 78.06M
Stochastic %K 48%
Beta 1.85
Analysts Strong Sell
Price Target $19.43

Company Profile

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was in...

Industry: Biotechnology
Sector: Healthcare
Phone: 908 517 9500
Fax: 908 375 8272
Address:
300 Connell Drive, Suite 4200, Berkeley Heights, United States
MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 12:58 PM
Enter: $CRMD Calls Strike Price: $12 Expiry Date: NOV 21 2025 Buy in Price: $0.65 - $0.70 Sell Price: $1.46 Profit : +124% (Turn every $1 into $2.24) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
Noname2022
Noname2022 Oct. 25 at 11:34 AM
$CRMD CorMedix expects to achieve $30 million in annualized cost synergies within 120 days of closing the Melinta deal, rising to as much as $45 million by 2026 — equivalent to ≈ $0.33–$0.50 per share in EPS accretion from synergies alone, even on a fully diluted (~92 million shares) basis.
1 · Reply
Noname2022
Noname2022 Oct. 25 at 11:24 AM
$CRMD Synergies ≈ 25 % OPEX Reduction
0 · Reply
Noname2022
Noname2022 Oct. 25 at 11:14 AM
$CRMD Added Q3 COGs and OPEX estimates
1 · Reply
Noname2022
Noname2022 Oct. 25 at 12:11 AM
$CRMD Pete got a promotion with reorg
2 · Reply
wolfofwestloop
wolfofwestloop Oct. 24 at 11:45 PM
$CRMD someone will come along and and buy them. At this share price and the rev/ebitda #'s this is to good to be true for Big Pharma not gobble up, 3.5-4.5B...
2 · Reply
Noname2022
Noname2022 Oct. 24 at 10:45 PM
$CRMD
1 · Reply
Derfzilla
Derfzilla Oct. 24 at 8:25 PM
$CRMD just another shitty day
0 · Reply
TSLA_S3XY
TSLA_S3XY Oct. 24 at 8:22 PM
$CRMD Another Day Closer!
0 · Reply
ByTheBeardOfZeus
ByTheBeardOfZeus Oct. 24 at 8:05 PM
$CRMD 8 years later I’m still feeling bamboozled…
0 · Reply
Latest News on CRMD
CorMedix: Strong Buy After Strong Developments And A Strategy Before Earnings

Oct 23, 2025, 11:29 PM EDT - 1 day ago

CorMedix: Strong Buy After Strong Developments And A Strategy Before Earnings

CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath

Oct 23, 2025, 8:30 AM EDT - 2 days ago

CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath

Halper Sadeh LLC Encourages CorMedix Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 22, 2025, 4:05 PM EDT - 2 days ago

Halper Sadeh LLC Encourages CorMedix Inc. Shareholders to Contact the Firm to Discuss Their Rights

CRMD, RANI, CELC, RAPT: four biotech stocks flying high today and why

Oct 20, 2025, 9:42 AM EDT - 5 days ago

CRMD, RANI, CELC, RAPT: four biotech stocks flying high today and why

CELC RANI RAPT

CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance

Oct 20, 2025, 7:30 AM EDT - 5 days ago

CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance

CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO

Sep 29, 2025, 8:30 AM EDT - 26 days ago

CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO

CorMedix: Strong Adoption Curve And Policy Environment

Sep 22, 2025, 4:46 AM EDT - 4 weeks ago

CorMedix: Strong Adoption Curve And Policy Environment

CorMedix Inc. (CRMD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 10, 2025, 1:18 PM EDT - 6 weeks ago

CorMedix Inc. (CRMD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

CorMedix Announces Strategic Minority Investment in Talphera

Sep 8, 2025, 8:30 AM EDT - 6 weeks ago

CorMedix Announces Strategic Minority Investment in Talphera

TLPH

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

Sep 8, 2025, 8:30 AM EDT - 6 weeks ago

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

TLPH

CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team

Sep 2, 2025, 7:30 AM EDT - 7 weeks ago

CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team

CorMedix to Participate in Upcoming Investor Conferences

Aug 28, 2025, 8:30 AM EDT - 2 months ago

CorMedix to Participate in Upcoming Investor Conferences

CorMedix: The Undervalued Breakthrough

Aug 26, 2025, 2:41 AM EDT - 2 months ago

CorMedix: The Undervalued Breakthrough

CorMedix, Inc. (CRMD) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 3:16 PM EDT - 2 months ago

CorMedix, Inc. (CRMD) Q2 2025 Earnings Call Transcript

CorMedix to Buy Melinta Therapeutics for $300 Million

Aug 7, 2025, 10:49 AM EDT - 2 months ago

CorMedix to Buy Melinta Therapeutics for $300 Million

Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry Leadership

Aug 7, 2025, 7:10 AM EDT - 2 months ago

Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry Leadership

CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings

Aug 7, 2025, 7:00 AM EDT - 2 months ago

CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings

Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 7, 2025, 7:00 AM EDT - 2 months ago

Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

CorMedix Analyst Says Investors Could Be Further Rewarded

Jun 30, 2025, 2:24 PM EDT - 4 months ago

CorMedix Analyst Says Investors Could Be Further Rewarded

CorMedix Seems Significantly Undervalued

Jun 30, 2025, 2:14 PM EDT - 4 months ago

CorMedix Seems Significantly Undervalued

Concentrix Posts Downbeat Earnings, Joins CorMedix And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Jun 27, 2025, 9:09 AM EDT - 4 months ago

Concentrix Posts Downbeat Earnings, Joins CorMedix And Other Big Stocks Moving Lower In Friday's Pre-Market Session

CNXC

CorMedix Inc. Announces Pricing of Public Offering of Common Stock

Jun 27, 2025, 8:00 AM EDT - 4 months ago

CorMedix Inc. Announces Pricing of Public Offering of Common Stock

CorMedix Inc. Announces Proposed Public Offering of Common Stock

Jun 26, 2025, 4:01 PM EDT - 4 months ago

CorMedix Inc. Announces Proposed Public Offering of Common Stock

CorMedix inc. Announces Customer Implementation

Jun 23, 2025, 7:30 AM EDT - 4 months ago

CorMedix inc. Announces Customer Implementation

CorMedix: DefenCath In Exponential Growth Phase With Robust Market Position

Jun 5, 2025, 12:37 AM EDT - 5 months ago

CorMedix: DefenCath In Exponential Growth Phase With Robust Market Position

CorMedix: Exceeding Expectations

Jun 4, 2025, 12:41 PM EDT - 5 months ago

CorMedix: Exceeding Expectations

CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference

May 30, 2025, 8:30 AM EDT - 5 months ago

CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference

CorMedix Inc. to Participate in the RBC Global Healthcare Conference

May 15, 2025, 8:30 AM EDT - 5 months ago

CorMedix Inc. to Participate in the RBC Global Healthcare Conference

CorMedix, Inc. (CRMD) Q1 2025 Earnings Call Transcript

May 6, 2025, 11:59 AM EDT - 6 months ago

CorMedix, Inc. (CRMD) Q1 2025 Earnings Call Transcript

CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

May 6, 2025, 7:30 AM EDT - 6 months ago

CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025

Apr 29, 2025, 8:30 AM EDT - 6 months ago

CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025

Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance

Apr 8, 2025, 7:30 AM EDT - 7 months ago

Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance

CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

Apr 2, 2025, 8:30 AM EDT - 7 months ago

CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

CorMedix: A Fair-Priced Biotech Company With A Bright Future

Mar 28, 2025, 3:01 AM EDT - 7 months ago

CorMedix: A Fair-Priced Biotech Company With A Bright Future

CorMedix Inc. (CRMD) Q4 2024 Earnings Call Transcript

Mar 25, 2025, 10:51 AM EDT - 7 months ago

CorMedix Inc. (CRMD) Q4 2024 Earnings Call Transcript

CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 25, 2025, 7:30 AM EDT - 7 months ago

CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

CorMedix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Mar 24, 2025, 9:21 AM EDT - 7 months ago

CorMedix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025

Mar 18, 2025, 8:30 AM EDT - 7 months ago

CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025

CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update

Jan 7, 2025, 7:30 AM EST - 10 months ago

CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update

CorMedix Inc. Added to Nasdaq Biotechnology Index

Dec 19, 2024, 8:30 AM EST - 11 months ago

CorMedix Inc. Added to Nasdaq Biotechnology Index

CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products

Nov 26, 2024, 8:30 AM EST - 11 months ago

CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products

Stock Picks From Seeking Alpha's October 2024 New Analysts

Nov 8, 2024, 8:00 AM EST - 1 year ago

Stock Picks From Seeking Alpha's October 2024 New Analysts

ACGL AMCX AMPS APOG AVRE BHP BILL

MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 12:58 PM
Enter: $CRMD Calls Strike Price: $12 Expiry Date: NOV 21 2025 Buy in Price: $0.65 - $0.70 Sell Price: $1.46 Profit : +124% (Turn every $1 into $2.24) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
Noname2022
Noname2022 Oct. 25 at 11:34 AM
$CRMD CorMedix expects to achieve $30 million in annualized cost synergies within 120 days of closing the Melinta deal, rising to as much as $45 million by 2026 — equivalent to ≈ $0.33–$0.50 per share in EPS accretion from synergies alone, even on a fully diluted (~92 million shares) basis.
1 · Reply
Noname2022
Noname2022 Oct. 25 at 11:24 AM
$CRMD Synergies ≈ 25 % OPEX Reduction
0 · Reply
Noname2022
Noname2022 Oct. 25 at 11:14 AM
$CRMD Added Q3 COGs and OPEX estimates
1 · Reply
Noname2022
Noname2022 Oct. 25 at 12:11 AM
$CRMD Pete got a promotion with reorg
2 · Reply
wolfofwestloop
wolfofwestloop Oct. 24 at 11:45 PM
$CRMD someone will come along and and buy them. At this share price and the rev/ebitda #'s this is to good to be true for Big Pharma not gobble up, 3.5-4.5B...
2 · Reply
Noname2022
Noname2022 Oct. 24 at 10:45 PM
$CRMD
1 · Reply
Derfzilla
Derfzilla Oct. 24 at 8:25 PM
$CRMD just another shitty day
0 · Reply
TSLA_S3XY
TSLA_S3XY Oct. 24 at 8:22 PM
$CRMD Another Day Closer!
0 · Reply
ByTheBeardOfZeus
ByTheBeardOfZeus Oct. 24 at 8:05 PM
$CRMD 8 years later I’m still feeling bamboozled…
0 · Reply
altair787
altair787 Oct. 24 at 8:00 PM
$CRMD Joe , thanks for another lousy week watching your little foray into feeling like a big guy. Too bad investors are wondering why we are here? Oh wait, I know, the future. Time is money, unfortunately. Get in gear!
0 · Reply
wellthatescalatedquickly
wellthatescalatedquickly Oct. 24 at 7:54 PM
$CRMD Making money everywhere else but with this one
0 · Reply
golfguy42360
golfguy42360 Oct. 24 at 7:24 PM
$CRMD CRMD stands for crooks raising my debt.
0 · Reply
AscendVentures
AscendVentures Oct. 24 at 7:14 PM
$CRMD mt sDNA incumbents posted CRC sensitivity near 92 percent and specificity around mid 80s while catching AA about 43 to 50. Beating AA while matching CRC is the golden ticket. That is how you pull users from entrenched brands
1 · Reply
WARRENBUFFETSIGNAL
WARRENBUFFETSIGNAL Oct. 24 at 6:42 PM
$CRMD BULLISH
0 · Reply
Klyvor_2677
Klyvor_2677 Oct. 24 at 6:25 PM
$CRMD Broke 2.03 on over 1M volume. This is a power move. No signs of slowing. NXXT
0 · Reply
trd4dollaBulls
trd4dollaBulls Oct. 24 at 6:04 PM
$CRMD - I don’t care if it’s just up by a penney- just close green!!!
0 · Reply
BooyaTrades
BooyaTrades Oct. 24 at 5:04 PM
$CRMD $375M revenue in 2025. Market cap of $875M. $100M in cash by EOY. Can someone explain this to me?
2 · Reply
TSLA_S3XY
TSLA_S3XY Oct. 24 at 5:00 PM
$CRMD Even Though We Got Preliminary Revenues Monday & Stronger Guidance We Are DOWN On The Week. Park Money Elsewhere Is A Good Idea.
0 · Reply
BioLove
BioLove Oct. 24 at 4:32 PM
$CRMD $AKBA deerfield keeping the doors wide open for shorting. This price movement defies all logic...but they have it made. Short, accumulate , little to no risk...all while knowing that the numbers are phenomenal and the stock will eventually rise on the news. This is such bs for thr longs.
0 · Reply
DocJuggernaut
DocJuggernaut Oct. 24 at 4:13 PM
$CRMD stock reminds me of PLTR prior to it taking off when it was still in the teens. Funds shorted it heavily, shook the tree hard and got retail to bail so they could buy and be under them. It worked very well. Institutional owndership went from 10%ish to now around 50%. Currently, per the NASDAQ, CRMD has around 44% institutional ownership that continues to grow. Perfect time to accumulate, imo, as it's only a matter of time before the stock comes back to reality. With a forward p/e of about 5 and earnings around the corning, that day is very near.
1 · Reply
golfguy42360
golfguy42360 Oct. 24 at 4:06 PM
$CRMD Can always count on this to be my turd of the day.$VVOS $PSQH $LITM
0 · Reply